Industry Symposium - Roche: Heading to the future of clinical research in neuromuscular disorders

12:00 • SYMP2L1 • Welcome and introductions > F. Francesco MUNTONI (London, Uk) 12:05 • SYMP2L2 • Seeking a better understanding of emerging therapies in neuromuscular disorders > F. Francesco MUNTONI (London, Uk) 12:15 • SYMP2L3 • Innovative outcome measures: effective and personalised assessments in neuromuscular disorders > C. Charlotte LILIEN (Oxford, Uk) 12:30 • SYMP2L4 • Innovative biomarkers: evaluating neuromuscular fatigue > G. Guillaume MILLET (Saint Etienne, France) 12:45 • SYMP2L5 • Panel discussion and Q&A